A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow

5.9K views

⸱

DOI:

10.3791/60323

⸱

October 31st, 2019

 ,  ,  , 
1Institut für Mikrobiologie, Technische Universität Braunschweig, 2Devision of Infection Medicine, Department of Clinical Science, Lund University, 3Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Ludwig Maximilians University, 4Department of Molecular Infection Biology, Helmholtz Center for Infection Research

In This Article

Summary

This study describes the microscopic monitoring of pneumococcus adherence to von Willebrand factor strings produced on the surface of differentiated human primary endothelial cells under shear stress in defined flow conditions. This protocol can be extended to detailed visualization of specific cell structures and quantification of bacteria by applying differential immunostaining procedures.

Abstract

Interaction of Streptococcus pneumoniae with the surface of endothelial cells is mediated in blood flow via mechanosensitive proteins such as the Von Willebrand Factor (VWF). This glycoprotein changes its molecular conformation in response to shear stress, thereby exposing binding sites for a broad spectrum of host-ligand interactions. In general, culturing of primary endothelial cells under a defined shear flow is known to promote the specific cellular differentiation and the formation of a stable and tightly linked endothelial layer resembling the physiology of the inner lining of a blood vessel. Thus, the functional analysis of interactions between bacterial pathogens and the host vasculature involving mechanosensitive proteins requires the establishment of pump systems that can simulate the physiological flow forces known to affect the surface of vascular cells.

The microfluidic device used in this study enables a continuous and pulseless recirculation of fluids with a defined flow rate. The computer-controlled air-pressure pump system applies a defined shear stress on endothelial cell surfaces by generating a continuous, unidirectional, and controlled medium flow. Morphological changes of the cells and bacterial attachment can be microscopically monitored and quantified in the flow by using special channel slides that are designed for microscopic visualization. In contrast to static cell culture infection, which in general requires a sample fixation prior to immune labeling and microscopic analyses, the microfluidic slides enable both the fluorescence-based detection of proteins, bacteria, and cellular components after sample fixation; serial immunofluorescence staining; and direct fluorescence-based detection in real time. In combination with fluorescent bacteria and specific fluorescence-labeled antibodies, this infection procedure provides an efficient multiple component visualization system for a huge spectrum of scientific applications related to vascular processes.

Introduction

The pathogenesis of pneumococcus infections is characterized by a multifaceted interaction with a diversity of extracellular matrix compounds and components of the human hemostasis, such as plasminogen and VWF1,2,3,4,5,6,7,8. The multidomain glycoprotein VWF serves as key regulator of a balanced hemostasis by mediating thrombocyte recruitment and fibrin incorporation at the site of vascular thrombus formation9. The importance of functional, active VWF for bleeding control and wound healing is demonstrated by von Willebrand’s disease, a common inherited bleeding disorder10.

Globular VWF circulates in the human blood system at a concentration of up to 14.0 µg/mL11,10. In response to vascular injury, the local release of VWF by endothelial Weibel Palade Bodies (WBP) is markedly increased11,12. Previous studies show that pneumococcus adherence to human endothelial cells and its production of the pore-forming toxin pneumolysin significantly stimulates luminal VWF secretion13. The hydrodynamic forces of the blood flow induce a structural opening of the mechanoresponsive VWF domains. At flow rates of 10 dyn/cm2 the VWF multimerizes to long protein strings of up to several hundred micrometers in length that remain attached to the subendothelium10,12.

To understand the function of multimerized VWF strings generated under shear stress in the interaction of pneumococcus with the endothelial surface, a microfluidic-based cell culture infection approach was established. A microfluidic device with a software-controlled air-pressure pump system was used. This enabled a continuous, unidirectional recirculation of cell culture medium with a defined flow rate. Thereby, the system applied a defined shear stress on the surface of endothelial cells, which remained attached inside specialized channel slides. This approach enabled the simulation of the shear force within the blood stream of the human vascular system, in which VWF strings are generated on differentiated endothelial cells under defined constant flow conditions. For this purpose, the endothelial cells were cultivated in specific channel slides (see Table of Materials), which were adapted for microscopic analyses during flow. The microfluidic pump system provided the highly defined and controlled shear stress situation required for the formation of extended VWF strings on the confluent endothelial cell layer. After the stimulation of VWF-secretion of confluently grown human umbilical vein endothelial cells (HUVEC) by histamine supplementation, the string formation was induced by applying a shear stress (ԏ) of 10 dyn/cm2. The shear stress is defined as the force acting on the cell layer. It is calculated approximately according to Cornish et. al.14 with equation 1:
Torsion formula τ=(6η/h²w)Φ; equation for shear stress analysis.

Where ԏ = shear stress in dyn/cm2, η = viscosity in (dyn∙s)/cm2, h =half of channel height, w = half of channel width, and Φ = flowrate in mL/min.

The result of equation 1 depends on the different heights and widths of the different slides used (see Table of Materials). In this study a Luer channel slide of 0.4 µm resulting in a chamber slide factor of 131.6 was used (see formula 2).
Static equilibrium, formula τ=131.6×η×Φ, equations for torque analysis.

Viscosity of the medium at 37 °C is 0.0072 dyn∙s/cm² and a shear stress of 10 dyn/cm² was used. This resulted in a flow rate of 10.5 mL/min (see formula 3).
Equation of luminous flux calculation Φ=10/(0.0072×131.6)=10.5, featuring optics formula.

Here, the adaptation and advancement of a microfluidic cell culturing procedure using a unidirectional laminar flow system for the investigation and visualization of bacterial infection mechanisms in the host vasculature is described in detail. The generation of VWF strings on endothelial layers can also be stimulated by using other pump systems that are able to apply a continuous and steady shear stress15.

After cultivation of primary endothelial cells to confluence in flow and stimulation of VWF string formation, pneumococci expressing red fluorescence protein (RFP)16 were added to the endothelial cell layer under constant microscopic control. The attachment of bacteria to VWF strings on the surface of endothelial cells was microscopically visualized and monitored for up to three hours in real time by using VWF-specific fluorescent-labelled antibodies. With this approach, the role of VWF as an adhesion cofactor promoting bacterial attachment to the vascular endothelium was determined8.

In addition to the microscopic visualization of protein secretion and conformational changes, this method could be used to monitor single steps of bacterial infection processes in real time and to quantify the amount of attached bacteria at different time points of infection. The specific software-controlled pump system also provides the possibility to culture the endothelial cells in defined constant flow conditions for up to several days and enables a defined pulsed medium flow incubation. Moreover, this method can be applied using different cell types. Adapting the staining protocol also enables the detection and visualization of bacteria internalized into eukaryotic cells.

This manuscript describes this advanced experimental protocol that can be used as a defined, reliable, and reproducible approach for an efficient and versatile characterization of pathophysiological processes.

Access restricted. Please log in or start a trial to view this content.

Protocol

The microfluidic cell cultivation was performed with commercial primary human umbilical vein endothelial cells (HUVEC). The company isolated the cells with informed consent of the donor. This study was approved by the Ethics Committee of Doctors Chamber of the Federal State Baden-Wuerttemberg with the reference number 219-04.

NOTE: See Table of Materials for protocol supplies.

1. Precultivation of Primary Endothelial Cells

  1. Thaw a frozen glycerol vial containing 1 x 105 primary HUVEC from three different donors gently at 37 °C and seed the cells in 7 mL of prewarmed endothelial cell growth medium (ECGM, ready to use with supplements) in a 25 cm2 cell flask.
    NOTE: The primary endothelial cells lose differentiation capacity after more than 5 proliferation cycles. Therefore, only cells with less than 5 passages can be used if high grades of cell differentiation are required.
  2. Cultivate the cells at 37 °C in 5% CO2 atmosphere for 60 min to allow surface attachment and exchange the ECGM cell culture medium to get rid of residue from cryoconservation.
  3. Continue culturing the cells at 37 °C in 5% CO2 atmosphere until they form a subconfluent cell layer.
    NOTE: The HUVEC must not grow to a confluent layer since the tight cell-cell contacts prevent formation of a stable cell layer later in flow.

2. Precultivation of Streptococcus pneumoniae

CAUTION: Streptococcus pneumoniae is a biosafety level 2 agent and is only allowed to be cultured in biosafety level 2 laboratories. Use a clean bench classified for safety level 2 for all bacterial treatments, strictly avoid aerosol formation, and use a centrifuge with aerosol protection for sedimentation of bacteria.

  1. Inoculate a Columbia blood agar plate with Streptococcus pneumoniae clinical isolate ATCC11733 derived from a glycerol stock constantly stored at -80 °C and cultivate the agar plate overnight at 37 °C and 5% CO2.
  2. Prepare 40 mL of Todd Hewitt liquid broth supplemented with 1% yeast extract (THY) and 15 mL of sterile phosphate-buffered saline (PBS) pH 7.4, for bacterial cultivation and washing steps.
  3. Use a sterile tube for bacterial cultivation and inoculate the liquid culture broth with bacterial mass. Control the amount of inoculation by photometric measurement of 1 mL aliquots at 600 nm against non-inoculated liquid broth as reference. Fill in bacterial mass into the liquid broth until it reaches an optical density at 600 nm (OD600) of 0.15.
  4. Incubate the inoculated liquid broth without shaking at 37 °C and 5% CO2 and determine the OD600 every 30 min by measuring 1 mL aliquots using plastic cuvettes.
  5. As soon as the bacterial culture has reached an OD600 of 0.4, which corresponds to the exponential growth phase, centrifuge the bacterial culture suspension for 10 min at 1,000 x g at room temperature (RT).
    NOTE: Do not allow a pneumococcus culture to reach an OD600 of more than 1.0, because a high pneumococcus culture density is known to trigger bacterial autolysis, which might affect overall bacterial fitness.
  6. Resuspend the bacterial sediment gently with 10 mL PBS and sediment again for 10 min at 1,000 x g at RT.
  7. Resuspend the washed bacterial sediment gently in 1 mL PBS and determine the OD600 of 10 µL of the bacterial suspension using 1 mL of PBS as a reference.
  8. Adjust the amount of bacteria in PBS to an OD600 of 2.0. According to formerly determined bacterial counting, an OD600 of 2.0 corresponds to 2 x 109 colony forming units (CFU). Immediately proceed with the infection procedure to prevent bacterial autolysis.

3. Endothelial Cell Cultivation of HUVEC Under Microfluidic Conditions

  1. Detach the primary endothelial cells from the cell culture flask by controlled proteolysis. Perform the following steps in a sterile environment using a clean bench. Prepare a volume of 15 mL of sterile PBS for the washing steps.
    1. Remove the ECGM from a subconfluently-grown HUVEC layer and wash the cell layer with 10 mL PBS using a serological pipette to get rid of the cell culture medium.
    2. Incubate the washed HUVEC with 3 mL of 37 °C prewarmed cell dissociation solution for cell detachment for 5 min at 37 °C. Observe the proteolytic cell detachment by microscopic monitoring each minute.
    3. Pipette the detached cell suspension into a tube containing 7 mL of ECGM supplemented with 2% fetal calf serum (FCS) for stopping proteolysis and sediment the cells for 3 min at 220 x g at RT.
    4. Remove the supernatant and resuspend the HUVEC in 250 µL of ECGM supplemented with 5% FCS and 1 mM MgSO4. Use 10 µL of the cell suspension for cell counting using a Neubauer cell counting chamber and adjust the cell count to 4 x 106 cells/mL ECGM supplemented with 5% FCS and 1 mM MgSO4.
      NOTE: For each flow experiment 30 mL of ECGM medium supplemented with 5% FCS and with 1 mM MgSO4 will be required. From here on this medium composition is named ECGMS-medium. The increase of FCS concentration in the culture medium from 2% to 5% supports cell attachment and cell viability of HUVEC seeded in the channel slide. The medium supplements FCS and MgSO4 substantially stabilize the cell attachment of HUVEC under shear stress conditions.
  2. Seed and cultivate the HUVEC in a channel slide. Work in a sterile environment using a clean bench. The cells will be cultivated under shear stress for 2 days followed by infection with bacteria and microscopic monitoring for another 2 h.
    1. Equilibrate a channel slide, a perfusion set 1.6 mm in diameter and 50 cm in length, an aliquot of the ECGMS-medium, and a Luer channel slide 0.4 µm in height, for 24 h in an incubator with 5% CO2 atmosphere at 37 °C to reduce the number of air bubbles.
      NOTE: This procedure is recommended to degas the plastic equipment and to prewarm the medium, the perfusion tubes, and the reservoirs. If materials or liquids have been stored at RT or in the refrigerator, gases dissolved in the plastic and liquids will be released when heated up in the incubator during the experiment. Gas bubbles will then appear. Degassing all plastic components before the experiment will eliminate this effect. Each time the system is taken out of the incubator, the process of gas absorption begins again. Therefore, work quickly at RT and never leave the fluidic unit outside the incubator for longer time periods.
    2. Use a pipette to inject 100 µL of a 2% sterile-filtered porcine gelatin solution in PBS solution into one of the reservoirs of a temperature-equilibrated channel slide. Incubate the gelatin-solution for 1 h at 37 °C and rinse the channel of the slide with 1 mL PBS under sterile conditions using a 1 mL Luer syringe.
    3. Place the gelatin-coated channel slide on a thin polystyrene or styrofoam plate to prevent a drop in the slide temperature. Add 100 µL of the 4 x 106/mL HUVEC suspension with a 1 mL Luer syringe into the slide.
      NOTE: Placing the channel slide on the cold metal surface of the clean bench could decrease the temperature of the slide bottom, thereby generating cold stress to the endothelial cells. During cell pipetting hold the slide a bit upwards to let air bubbles rise and disappear from inside the slide.
    4. Incubate the channel slide with the HUVEC for 60 min at 37 °C and 5% CO2 and fill up the medium reservoirs at both ends of the channel slide with 60 µL ECGMS-medium each. Incubate for 1 h at 37 °C and 5% CO2.
  3. Adjust the microfluidic pump and the software settings.
    1. Connect the equilibrated perfusion set to the pump unit, fill with 13.6 mL of ECGMS-medium, and start the pump control software. Select the adequate perfusion set and type of chamber slide using the scroll down windows in the menu of the fluidic unit set up. Choose 0.007 (dyn∙s/cm2) in the software for medium viscosity. (Refer to the pressure pump software settings marked with red arrows in Supplementary Figure 1).
    2. Outside of the incubator, connect a glass bottle filled with drying silica beads to the air pressure tubing (refer to Figure 1, Inset 3). The air of the pressure pump circulates between the perfusion reservoirs and the pump and must be dry before reentering the pump device. Select Flow Parameters in the software menu, set the pressure to 40 mbar, and flush the pump tubes with the liquid medium by starting the continuous medium flow. (These settings are also indicated by red arrows in Supplementary Figure 1).
    3. Program the desired shear stress cycles of flow cultivation. Start with 5 dyn/cm2, control balanced reservoir pumpinng and assure that no air bubbles are circulating in the pump system.
      NOTE: The wall shear stress in a channel slide depends on the flow rate and the viscosity of the perfusion medium. If using another pump system, please refer to the equations described in the introduction to set a flow rate generating the desired shear stress level. The described settings correspond to a flow rate of 5.42 mL/min. (An exemplary screen shot showing the adequate flow parameter settings in the pressure pump software is shown in Supplementary Figure 2).
    4. Stop the flow circulation in the pump control software and hold the medium flow in the perfusion tubing by clamping the tubes near the Luer connections. Connect the channel slide, thereby avoiding air bubbles, and place the fluidic unit with the connected channel slide in a CO2 incubator at 37 °C and 5% CO2. Start the shear stress at 5 dyn/cm2 for 30 min to smoothly adapt the cells to the forces generated by the shear stress before accelerating the shear stress level (see Supplementary Figure 3).
      NOTE: Take care that no air bubbles remain in the tube system or in the slide after connectinng to the tube system because the movement of air bubbles in the flow might lead to cell detachment.
    5. Accelerate the shear stress to 10 dyn/cm2 (which correspond to 10.86 mL/min in this flow setting) and incubate the channel slide in continuous shear stress for 48 h in a small CO2 incubator at 37 °C and 5% CO2 to allow cell differentiation (the respective software settinngs are indicated with red arrows in Supplementary Figure 4).
      NOTE: HUVEC cells tend to detach from the channel surface if flow cultivation is directly started at 10 dyn/cm2. The cells remain attached to the chamber surface if flow cultivation is started with less shear stress using 5 dyn/cm2 for a minimum of 30 min followed by increasing the shear stress slowly up to the desired 10 dyn/cm2. A shear stress of 10 dyn/cm2 is the minimum value in this perfusion setting required for VWF string formation.
    6. After 24 h of microfluidic cell cultivation, stop the medium flow with the pump control software exactly when a balanced medium level is reached in both medium reservoirs. Place the fluidic unit in a clean bench and remove 10 mL of the circulated cultivation medium of the perfusion reservoirs using a 10 mL serological pipette. Add 10 mL of ECGMS-medium into the reservoirs to renew the medium, place the fluidic unit back into the CO2 incubator at 37 °C and 5% CO2, and restart the fluidic cultivation using the pump control software.
      NOTE: The function of the pressure pump can suddenly be disrupted by laboratory machines such as large centrifuges, which might create a strong magnetic field disturbance. This sudden disruption might lead to cell detachment. Take care that such machines are not active near the pressure pump during the experiment.
    7. Start the prewarming of the temperature incubation chamber covering the stage of the fluorescence microscope to 37 °C for temperature equilibration 24 h before the microscopic visualization. After the microscope is prewarmed, start the microscope software control and adjust the principal settings for the fluorescence microscopic monitoring by selecting the appropriate filter settings (540 nm/590 nm for detection of the RFP-expressing bacteria and 470 nm/515 nm for detection of fluorescein emission of the FITC-conjugated VWF-specific antibodies). Prewarm an additional heating chamber for incubation of the fluidic unit at 37 °C. 
      NOTE: During the infection analyses and microscopic monitoring the temperature of the channel slide and the circulating medium should not decrease substantially, because this would generate cold stress on the cells. In general, the size of the temperature chambers covering the microscope stage is not enough to cover the whole fluidic unit. Therefore, the use of an additional heating chamber prewarmed to 37 °C is recommended.
    8. For microscopic visualization, place the fluidic unit into the 37 °C prewarmed heating chamber and place the channel slide on a stage of the 37 °C prewarmed microscope. 
      NOTE: For microscopic visualization, the fluidic unit and the channel slide needed to be removed from the CO2 incubator due to the limited length of the perfusion tubing. If infection times and microscopic monitoring longer than 180 min are required outside the 5% CO2 atmosphere for pH buffering, a pH-buffered medium should be used for microfluidic cultivation.
    9. Control the cell morphology and the integrity of the HUVEC layer prior to injection of histamine and bacteria to the flow circulation throughout the time of the flow experiment and after finishing the flow experiment using the bright field mode of the microscope.

4. Induction of VWF-release and Visualization of Multimerized VWF Strings

  1. Maintain the flow setting, because a shear stress of 10 dyn/cm2 is required to trigger the multimerization of VWF to long strings of up to 200 MDa. Induce the release of VWF from endothelial WPB by injecting 136 µL of a 100 mM histamine stock solution into the ECGMS-medium circulating in the perfusion tubing using an injection port. The final concentration of histamine in the flow medium will be 1 mM. If no injection port is available, the histamine can be added alternatively by pipetting into the medium of the pump reservoirs.
  2. For immunofluorescence detection of multimerized VWF strings, stop the flow when a balanced medium level in the reservoirs is reached, and inject 20 µg of a VWF-specific FITC-conjugated antibody in a volume of 200 µL PBS (pH 7.4) into the circulating 13.6 mL of ECGMS-medium using an injection port. If no injection port is available, the antibody can be added alternatively by pipetting into the medium of the pump reservoirs. This results in a final antibody concentration of 1.3 µg/mL.
  3. For microscopic scanning of several fields of view in a short time, use the fluorescence unit of the microscope with a Xenon fluorescence device at 30% power and an epifluorescence camera. Monitor the shape and morphology of the HUVEC layer with the bright field mode to select representative cells suitable for the VWF-strings visualization.
  4. For visualization of green fluorescent VWF strings, select a 63x/1.40 oil objective and a 470 nm detection filter in the fluorescence unit menu of the microscope software (LasX). Create snapshots of Z-stacks of at least 50 representative field views, each containing approximately 10 morphologically intact HUVEC. For quantification of the green fluorescent VWF strings at different time points, scan several fields of view.

5. Microscopic Evaluation of Bacterial Attachment to VWF-strings in Flow in Real Time

  1. Quantify pneumococcal attachment to the VWF-strings generated on HUVEC cell surfaces via immunofluorescence detection.
    1. Hold the flow and inject 1.35 x 108 CFU/mL RFP-expressing pneumococci in a maximum volume of 1 mL into the ECGMS-medium using the injection port. Alternatively, pipette the bacteria into the medium in the pump reservoir. Restart the shear stress at 10 dyn/cm2 to let the bacteria circulate within the pump system.
    2. Select a 63x oil-immersion objective for microscope magnification and adjust the fluorescence filter settings in the microscope software to the RFP-channel (540 nm detection filter) for detection of RFP-expressing pneumococci.
    3. For quantification of bacterial attachment to the VWF strings, stop the flow and create snapshots of Z-stacks of at least 30 representative field views, each containing approximately 10 morphologically intact HUVEC, and count the amount of pneumococci.
    4. Use the ANOVA one-factorial statistics algorithm in order to evaluate the data, followed by a post hoc two-tailed unpaired sample test for detailed statistical comparison. P values of <0.05 were considered statistically significant.

6. Microscopic Evaluation of Bacterial Attachment to VWF-strings After Sample Fixation

  1. Sample the fixation prior to immunofluorescence staining.
    1. Stop the flow, remove 10 mL of ECGMS-medium from the pump reservoirs, and add 10 mL of PBS supplemented with 5% paraformaldehyde (PFA). Let the PFA solution circulate for 10 min at a shear stress of 10 dyn/cm2.
    2. Disconnect the channel slide from the pump unit.
  2. Block unspecific binding sites on the cell surface and perform immunodetection of VWF strings and attached bacteria.
    1. Prepare 4 mL of a washing solution containing 100 mM Na2CO3 (pH 9.2) supplemented with 4% sucrose for all washing steps. Prepare 1 mL of a blocking solution containing 100 mM Na2CO3 (pH 9.2) supplemented with 4% sucrose and 2% bovine serum albumin (BSA) for blocking of unspecific binding sites.
    2. Wash the PFA-incubated channel slide 3x using a 1 mL Luer syringe to inject 200 µL of the washing solution and incubate the slide for 120 min at RT with 200 µL blocking solution.
    3. Prepare 4 mL of another blocking solution containing 100 mM Na2CO3, (pH 9.2) supplemented with 4% sucrose and 0.5% BSA for the dilution of the antibodies. Use 200 µL of this blocking solution to dilute the pneumococcus-specific rabbit antiserum 1:100. Use 200 µL of this blocking solution to dilute the VWF-specific mouse antibody 1:50 to make a VWF-specific antibody concentration of 4 µg/mL. Dilute the AlexaFluor488-conjugated secondary antibody from a 2 mg/mL stock solution 1:100 in 200 µL of PBS (pH 7.4) to generate a final concentration of 20 µg/mL.
      NOTE: In the described immunofluorescence settings, the antibody detection delivered optimal results when the antibodies were diluted in the above-mentioned alkaline carbonate buffer. Based on previous results, the recommended blocking solutions and the amount of antibodies are suitable for many applications. However, different experiments might require individual optimization of the antibody combination, antibody concentration, incubation time, and constitution of the blocking buffer. As an alternative, a phosphate-buffered system with a neutral pH range might be suitable or even preferred as an incubation buffer. In case of weak fluorescence signals, the concentration of secondary antibody should be increased. If too much unspecific fluorescence background noise is detected, the amount of blocking substances should be increased.
    4. For VWF-immunofluorescence staining, wash the channel slide using a 1 mL Luer syringe by injecting 200 µL of the washing solution 3x and incubate the slide with the 1:50 diluted VWF-specific antibody for 30 min at RT. Afterwards, wash the channel slide again 3x with 200 µL of the washing solution and incubate the slide with the 1:100 diluted AlexaFluor488-conjugated mouse-specific antibody for 30 min at RT. Finally, wash the channel slide again 3x with 200 µL of the washing solution.
      NOTE: The AlexaFluor-fluorophores are sensitive to bleaching. Therefore, the slide should be protected by keeping it in a dark chamber during the incubation steps with the fluorophore-conjugated antibodies.
    5. For immunodetection of the pneumococci, incubate the slide with a 1:100 diluted pneumococcus-specific rabbit antibody for 30 min at RT. Afterwards, wash the channel slide 3x with 200 µL of the washing solution and incubate the slide with 1:100 diluted AlexaFluor568-conjugated rabbit-specific antibody for 30 min at RT. Wash the channel slide again 3x with 200 µL of the washing solution.
    6. To stain the cellular actin cytoskeleton with fluorescent phalloidin, permeabilize the HUVEC by incubation with 120 µL of 0.1% Triton X-100 for 5 min at RT. Wash the channel slide 3x with 200 µL of the washing solution and incubate the slide with 120 µL of 1:1,000 diluted AlexaFluor350-conjugated phalloidin. This incubation step will visualize the polymerized actin cytoskeleton and allow monitoring of the cell shape and possible stress-induced morphological changes.
    7. Wash the channel slide 3x with 200 µL of the washing solution. Finally, wash the slide 4x with 200 µL ddH2O and visualize the green fluorescent VWF strings, the red fluorescent bacteria, and the blue fluorescent actin cytoskeleton using the appropriate filter settings on the fluorescence microscope.

Access restricted. Please log in or start a trial to view this content.

Results

Culturing primary HUVEC in a constant unidirectional flow results in the formation of a confluent and tightly packed cell layer that promotes the generation of cellular WPBs filled with the mechanosensitive VWF13,14. This protocol describes the use of an air pressure pump-based, pulseless recirculation system for infection analysis that requires mimicking the shear stress situation in the human blood flow.

This system enables a defined...

Access restricted. Please log in or start a trial to view this content.

Discussion

The simulation of bacterial interaction with mechanosensitive host proteins such as VWF requires a perfusable cell culture system that enables the generation of a defined, unidirectional, and continuous flow of liquids, thereby generating reliable shear stress. Several microfluidic pump systems have already been described. A comprehensive review from Bergmann et al. summarizes the key aspects of different two- and three-dimensional cell culture models17.

The microfluidi...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The project was funded by the DFG (BE 4570/4-1) to S.B.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1 mL Luer-syringeFisher Scientific10303002with 1 mL volume for gelatin injection using the luer-connection of the slides
2 mL Luer-syringeSarstedt9077136For pieptting/injecting fluids into the luer connections of the channel chamber slides
AccutaseeBioscience now thermo fisher00-4555-56protease mix used for gentle detachment of endothelial cells
AlexaFluor350-conjugated PhalloidinAbcamab176751no concentration available from the manufacturer, stock solution is sufficient for 300 tets, company recommends to use 100 µL of a 1:1,000 dilution, blue fluorescence (DAPI-filter settings)
AlexaFluor488-conjugated goat-derived anti-mouse antibodyThermo Fisher SientificA11001stock concentration: 2 mg/mL for immunostaining of human VWF in microfluidic slide after PFA fixation, green fluorescence
AlexaFluor568-conjugated goat-derived anti-rabbit-antibodyThermo Fisher ScientificA-11011stock concentration: 2 mg/mL for immunostaining of pneumococci in microfluidic slide after pFA fixation, red fluorescence
Bacto Todd-Hewitt-BrothBecton Dickinson GmbHBD 249210complex bacterial culture medium
Bovine Serum Albumin (BSA)Sigma AldrichA2153-25Gsolubilized, for preparation of blocking buffer
Cell culture flasks with filterTPP90026subcultivation of HUVEC in non-coated cell culture flasks of 25 cm2 surface
Centrifuge Allegra X-12RBeckman Coulter Life Sciences392304spinning down of bacteria (volumes of >2mL)
Centrifuge Allegra X-30Beckman Coulter Life SciencesB06314spinning down of eukaryotic cells
Centrifuge Z 216 MKHermle305.00 V05 - Z 216 Mspinning down of bacteria (volumes of less than 2 mL)
ChloramphenicolCarl Roth GmbH + Co. KG, Karlsruhe3886.2used in a concentration of 0.2 mg/mL for cultivation of pneumococci transformed with genetic construct carrying red fluorescent protein and chloramphenicol resistance cassette
Clamp for perfusion tubingibidi10821for holding the liquid in the tube bevor connecting the slide to the pump system
CO2-IncubatorFisher ScientificMIDI 40incubator size is perfectly adapted to teh size of the fluidic unit with connected channel slide and was used for flow cultivation at 37 °C and 5% CO2
CO2-IncubatorSanyoMCO-18 AICfor incubation of bacteria and cells in a defined atmosphere at 5% CO2 and 37 °C
Colombia blood agar platesBecton Dickinson GmbHPA-254005.06agar-based complex culture medium for S. pneumoniae supplemented with 7% sheep blood
ComputerDellLatitude 3440Comuter with pressure pump software
Confocal Laser Scanning Microscope (CLSM)LeicaDMi8An inverse microscope with a stage covered by a heatable chamber and with a fluorescence unit equipped with fluorescence filter, Xenon-light source (SP8, DMi8) and DFC 365 FX Kamera (1392 x 1040, 1.4 Megapixel)
Di Potassium hydrogen phosphate (KH2PO4)Carl Roth GmbH + Co. KG, Karlsruhe3904.1used for PBS buffer
Drying materialMerck101969orange silica beads for drying used in a glass bottle with a tubing adaptor
ECGM supplement MixPromocellC-39215supplement mix for ECGM -medium, required for precultivation of endothelial cells: 0.02 mL/mL Fetal calf serum, 0.004 mL/mL endothelial cell growth supplement, 0.1 ng/mL epidermal growth factor, 1 ng/mL basic fibroblast growth factor, 90 µg/mL heparin, 1 µg/mL Hydrocortisone
ECGMSPromocellC-22010ECGM supplemented with 5 % [w/w] FCS and 1 mM MgSO4 to increase cell adhesion
Endothelial Cell growth medium (ECGM, ready to use)PromocellC-22010culture medium of HUVECs, already supplemented with all components of the supplement mix
Fetal Calf Serum (FCS)biochrome now MerckS 0415supplement for cell culture, used for infection analyses
FITC-conjugated goat anti-human VWF antibodyAbcamab8822stock concentration: 10 mg/mL, for immunodetection of globular and multimerized VWF in flow
Fluidic Unitibidi10903fluidic unit for flow cultivation
Gelatin (porcine)Sigma AldrichG-1890-100gfor precoating of microslide channel surface
Histamine dihydrochlorideSigma AldrichH-7250-10MGfor induction of VWF secretion from endothelial Weibel Palade Bodies
Human Umbilical Vein Endothelial Cell (HUVEC)PromocellC-12203 Lot-Nr. 396Z042primary endothelial cells from pooled donor, stored crypcoserved in liquid nitrogen
Human VWF-specific antibody derived from mouse (monoclonal)Santa Cruzsc73268stock concentration: 200 µg/mL for immunostaining of VWF in microfluidic slide after PFA fixation
Injection Portibidi10820for injection of histamin or bacteria into the reservoir tubing during the flow circulation
Light microscopeZeissAxiovert 35Minverse light microscope for control of eukaryotic cell detachement and cell counting using a 40x water objective allowing 400x magnification
Luer-slides I0.4 (ibiTreat472microslides)ibidi80176physically modified slides for fludic cultivation (μ–Slide I0.4Luer with a channel hight of 0.4 mm, a channel volume of 100 μl, a growth area of 2.5 cm and a coating area of 25.4 cm2) suitable for all kinds of flow assay, the physical treatment generates a hydrophilic and adhesive surface.
Magnesium sulfate (MgSO4, unhydrated)Sigma AldrichM7506-500GFor preparation of ECGMS medium
Microfluidic Pumpibidi10905air pressure pump
Neubauer cell counting chamberKarl Hecht GmbH&Co KG40442002microscopic counting chamber for HUVECs
Paraformaldehyde 16% (PFA)Electron Microscopy Sciences15710-Sfor cross linking of samples
Perfusion Setibidi10964Perfusion Set Yellow/Green has a tubing diameter of 1.6 mm, a tube length of 50 cm, a total working volume of 13.6 mL, a dead tube volume of 2.8 mL and a reservoir size of 10 mL. combined with the µ-slide L0.4Luer, at 37 °C and a viscosity of 0.0072 dyn x s/cm2 a flow rate range of 3.8mL/min up to 33.9 mL/min and shear stress between 3.5 dyn/cm2 and 31.2 dyn/cm2 can be reached. with 50 cm lenght for microfluidic
Phosphate-buffered saline (PBS)the solution was prepared using the following chemicals: 0.2 g/L KCl, 1.44 g/L Na2HPO4, 0.24 g/L KH2PO4 , pH 7.4
Plastic cuvettesSarstedt67,741(2 x optic) for OD measurement at 600 nm
Pneumococcus-specific antiserumPinedaraised in rabbit using heat-inactivated Streptococcus pneumoniae NCTC10319 and D39, IgG-purified using proteinA-sepharose column.
Polystyrene or Styrofoam platethis is a precaution step to avoid cold stress on the cells seeded in the channel slides. Any type of styrofoam such as packaging box-material can be used. The plate might by 0.5 cm thick and should have a size of 20 cm2.
Potassium chloride (KCl)Carl Roth GmbH + Co. KG, Karlsruhe6781.1used for PBS buffer
Pump Control Software (PumpControl v1.5.4)ibidiv1.5.4Computer software for controlling the pressure pump, setting the flow conditions and start/end the flow
Reaction tubes 1.5/2.0 mLSarstedt72.706/ 72.695.500required for antibody dilutions
Reaction tubes with 50 mL volumeSarstedt6,25,48,004
RFP-expressing pneumococciNational Collection of Type Cultures, Public Health England10,319Streptococcus pneumoniae serotype 47 expressing RFP fused to ahistone-like protein integrated into the genome
Serological pipets 5, 10 mLSarstedt86.1253.025/ 86.1254.025for pipeting larger volumes
Sodium Carbonate (Na2CO3, water free)Sigma Aldrich451614-25Gfor preparation of 100 mM Sodium Carbonate buffer
Sodium dihydrogen phosphate (NaH2PO4)Carl Roth GmbH + Co. KG, KarlsruheP030.2used for PBS buffer
Spectral Photometer Libra S22Biochrom80-2115-20measurement of optical density (OD) of bacterial suspension at 600 nm
SucroseSigma AldrichS0389-500Gfor preparation of blocking buffer
Triton X-100Sigma AldrichT9284-500MLUsed in 0.1% end concentration diluted in dH20 for eukaryotic cell permeabilization after PFA fixation
Yeast extractoxoidLP0021bacteria are cultivated in THB supplement with 1% [w/w] yeast extract = complete bacterial cultivation medium THY

References

  1. Weiser, J. N., Ferreira, D. M., Paton, J. C. Streptococcus pneumoniae: transmission, colonization and invasion. Nature Reviews Microbiology. 16 (6), 355-367 (2018).
  2. Bergmann, S., Hammerschmidt, S. Versatility of pneumococcal surface proteins. Microbiology. 152, 295-303 (2006).
  3. Bergmann, S., et al. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. Journal of Cell Science. 122, 256-267 (2009).
  4. Bergmann, S., Schoenen, H., Hammerschmidt, S. The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells. International Journal of Medical Microbiology. 303, 452-462 (2013).
  5. Bergmann, S., Rohde, M., Chhatwal, G. S., Hammerschmidt, S. Alpha-enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Molecular Microbiology. 40, 1273-1287 (2001).
  6. Bergmann, S., et al. Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Molecular Microbiology. 49, 411-423 (2003).
  7. Bergmann, S., Rohde, M., Preissner, K. T., Hammerschmidt, S. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thrombosis and Haemostasis. 94, 304-311 (2005).
  8. Jagau, H., et al. Von willebrand factor mediates pneumococcal aggregation and adhesion in flow. Frontiers in Microbiology. 10, 511(2019).
  9. Tischer, A., et al. Enhanced local disorder in a clinically elusive von willebrand factor provokes high-affinity platelet clumping. Journal of Molecular Biology. 429, 2161-2177 (2017).
  10. Ruggeri, Z. M. Structure of von willebrand factor and its function in platelet adhesion and thrombus formation. Best Practice Research Clinical Haematology. 14, 257-279 (2001).
  11. Spiel, A. O., Gilbert, J. C., Jilma, B. Von willebrand factor in cardiovascular disease: Focus on acute coronary syndromes. Circulation. 117, 1449-1459 (2008).
  12. Springer, T. A. Von Willebrand factor, Jedi knight of the bloodstream. Blood. 124, 1412-1425 (2014).
  13. Luttge, M., et al. Streptococcus pneumoniae induces exocytosis of weibel-palade bodies in pulmonary endothelial cells. Cellular Microbiology. 14, 210-225 (2012).
  14. Cornish, R. J. Flow in a Pipe of Rectangular Cross-Section. Proceedings of the Royal Society A. 786, 691-700 (1928).
  15. Michels, A., Swystun, L. L., Mewburn, J., Albánez, S., Lillicrap, D. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation. Journal of Visualized Experiments. 14 (126), (2017).
  16. Kjos, M., et al. fluorescent Streptococcus pneumoniae for live-cell imaging of host-pathogen interactions. Journal of Bacteriology. 197, 807-818 (2015).
  17. Bergmann, S., Steinert, M. From single cells to engineered and explanted tissues: New perspectives in bacterial infection biology. International Reviews of Cell and Molecular Biology. 319, 1-44 (2015).
  18. Harrison, D. J., et al. Micromachining a miniaturized capillary electrophoresis-based chemical analysis system on a chip. Science. 261 (5123), 895-897 (1993).
  19. Magnusson, M. K., Mosher, D. F. Fibronectin: Structure, assembly, and cardiovascular implications. Arteriosclerosis, Thrombosis, and Vascular Biology. 18, 1363-1370 (1998).
  20. Zerlauth, G., Wolf, G. Plasma fibronectin as a marker for cancer and other diseases. The American Journal of Medicine. 77 (4), 685-689 (1984).
  21. Li, X. J., Valadez, A. V., Zuo, P., Nie, Z. 2012. Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis. 4, 1509-1525 (2019).
  22. Fiddes, L. K., et al. A circular cross-section PDMS microfluidics system for replication of cardiovascular flow conditions. Biomaterials. 31, 3459-3464 (2010).
  23. Schimek, K., et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab on a Chip. 13, 3588-3598 (2013).
  24. Pappelbaum, K. I., et al. Ultralarge von willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress. Circulation. 128, 50-59 (2013).
  25. Schneider, S. W., et al. Shear-induced unfolding triggers adhesion of von willebrand factor fibers. Proceedings of the National Academy of Sciences of the United States of America. 104, 7899-7903 (2007).
  26. Reneman, R. S., Hoek, A. P. G. Wall shear stress as measured in vivo: consequences for the design of the arterial system. Medical & Biological Engineering & Computing. 46 (5), 499-507 (2008).
  27. Valentijn, K. M., Sadler, J. E., Valentijn, J. A., Voorberg, J., Eikenboom, J. Functional architecture of Weibel- Palade bodies. Blood. 117, 5033-5043 (2011).
  28. Freshney, R. I. Culture of animal cells: A manual of basic Technique, 5th edition. , Wiley-Liss Publication, Wiley-Blackwell. (2005).
  29. Shaw, J. A. Epithelial cell culture- a practical approach. Shaw, A. J. , IRL Press at Oxford University Press. 218(1996).
  30. Elm, C., et al. Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. Journal of Biological Chemistry. 279 (8), 6296-6304 (2004).
  31. Nerlich, A., et al. Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism. Journal of Biological Chemistry. 284 (30), 20319-20328 (2009).
  32. Ho, C. T., et al. Liver-cell patterning lab chip: mimicking the morphology of liver lobule tissue. Lab on a Chip. 13, 3578-3587 (2013).
  33. Huh, D., et al. Reconstituting organ-level lung functions on a chip. Science. 328, 1662-1668 (2010).
  34. Harink, B., Le Gac, S., Truckenmuller, R., van Blitterswijk, C., Habibovic, P. Regeneration-on-a-chip? The perspectives on use of microfluidics in regenerative medicine. Lab on a Chip. 13, 3512-3528 (2013).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Microfluidic DeviceShear StressVon Willebrand FactorHUVEC CultureFluorescence MicroscopyBacterial AttachmentVWF Strings
Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow
Contact Us
Recommend to Library

Privacy

Terms of Use

Policies

Copyright © 2026 MyJoVE Corporation. All rights reserved.